Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Celularity Inc. Enters Partnership with MuseCell Innovations for $300 Million Manufacturing Project to Expand U.S. Biotech Jobs.

Aug 29, 2026•about 3 hours ago

Contract Type

partnership

Florham ParkBiotechnology

Description

Celularity Inc. has announced a new partnership with Singapore-based MuseCell Innovations that could generate $300 million in business and create over 200 jobs at its Florham Park facility. The collaboration involves establishing manufacturing capability for Dezawa MuseCells, with plans for additional projects if successful.

Company Information

Company

Celularity

Location

170 Park Avenue

Florham Park, New Jersey, United States

About

Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity’s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature’s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases.

Related People

Suggested for you
Robert
Likely contact at this company
••••••••@••••••••

See Robert's verified email →

Joseph
Likely contact at this company
••••••••@••••••••

See Joseph's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Celularity's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Celularity signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.